Bio-Thera Solutions, Ltd. (SHA:688177)
China
· Delayed Price · Currency is CNY 22.44
-0.18 (-0.80%)
At close: Mar 9, 2026
Bio-Thera Solutions Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -510.3 | -394.53 | -480.4 | 81.94 | Upgrade
|
| Depreciation & Amortization | - | 87.86 | 85.24 | 83.84 | 72.94 | Upgrade
|
| Other Amortization | - | 2.18 | 0.11 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.01 | -0.03 | -0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -2.95 | -6.92 | 0.07 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -1.23 | -3.87 | -25.03 | -27.6 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.23 | 0.19 | -0.71 | 0.9 | Upgrade
|
| Other Operating Activities | - | 20.86 | 11.78 | 0.63 | 0.69 | Upgrade
|
| Change in Accounts Receivable | - | 44.85 | -99.3 | 27.1 | 21.88 | Upgrade
|
| Change in Inventory | - | -21.87 | -69.33 | -71.8 | -44.47 | Upgrade
|
| Change in Accounts Payable | - | 299.37 | 41.14 | 53.48 | 129.99 | Upgrade
|
| Change in Other Net Operating Assets | - | 25.35 | -25.35 | - | - | Upgrade
|
| Operating Cash Flow | - | -55.65 | -460.87 | -412.82 | 236.27 | Upgrade
|
| Capital Expenditures | - | -126.85 | -262.14 | -258.82 | -77.89 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 0 | 0.03 | 0 | Upgrade
|
| Investment in Securities | - | 240 | 288 | -28 | 340 | Upgrade
|
| Other Investing Activities | - | 5.49 | 11.71 | 40.99 | 39.65 | Upgrade
|
| Investing Cash Flow | - | 118.64 | 37.57 | -245.8 | 301.76 | Upgrade
|
| Long-Term Debt Issued | - | 378.93 | 441.85 | 3 | 30 | Upgrade
|
| Total Debt Issued | - | 378.93 | 441.85 | 3 | 30 | Upgrade
|
| Long-Term Debt Repaid | - | -277.73 | -34.97 | -32.99 | -2.91 | Upgrade
|
| Total Debt Repaid | - | -277.73 | -34.97 | -32.99 | -2.91 | Upgrade
|
| Net Debt Issued (Repaid) | - | 101.2 | 406.88 | -29.99 | 27.09 | Upgrade
|
| Common Dividends Paid | - | -20.6 | -9.32 | -0.16 | -0.55 | Upgrade
|
| Other Financing Activities | - | 6.69 | -2.4 | - | - | Upgrade
|
| Financing Cash Flow | - | 87.28 | 395.16 | -30.15 | 26.54 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.61 | 0.57 | 0.77 | -0.8 | Upgrade
|
| Net Cash Flow | - | 150.88 | -27.58 | -688 | 563.77 | Upgrade
|
| Free Cash Flow | - | -182.5 | -723.01 | -671.64 | 158.38 | Upgrade
|
| Free Cash Flow Margin | - | -24.56% | -102.58% | -147.57% | 18.93% | Upgrade
|
| Free Cash Flow Per Share | - | -0.44 | -1.74 | -1.62 | 0.39 | Upgrade
|
| Cash Income Tax Paid | - | 19.94 | -23.92 | -34.41 | -24.37 | Upgrade
|
| Levered Free Cash Flow | - | -108.15 | -591.18 | -510.64 | 34.74 | Upgrade
|
| Unlevered Free Cash Flow | - | -95.31 | -584.69 | -510.6 | 35.23 | Upgrade
|
| Change in Working Capital | - | 347.69 | -152.84 | 8.78 | 107.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.